Trasylol Story A Sea Change For Medical Community
By Alan Haburchak
How does a drug marketed by a pharmaceutical giant go from superstar to scapegoat in a matter of mere months? That's what doctors who use the injectable drug Trasylol-Aprotinin are asking themselves after recent revelations that the drug, which is used to stop bleeding in 60 percent of heart surgery patients, causes side effects such as kidney failure, heart attack, encephalopathy, stroke and even death.
The drug, which is manufactured by Bayer AG and was approved in the United States in 1993, had been questioned in a January 2006 report by the New England Journal of Medicine, which found that Trasylol upped the risk of kidney failure after heart surgery by 259 percent and linked the drug with renal failure and future heart attacks.
Singing Its Praises
Ironically, the drug had been mentioned in The Washington Post in early January 2006 as an example of a drug so safe that it no longer required clinical study. The article stated that Trasylol dropped the risk of blood transfusions in bypass patients by one-third and that after only 12 of 64 clinical studies, its advantages were clear. Amazingly, the article stated that if researchers had used the positive information from previous studies, they would not have needed to run their own clinical trials.
Tides Turn for Trasylol
The above article ran on January 2, 2006. However, in only 24 days, the tide had turned for Trasylol after the New England Journal of Medicine published its study of over 1,000 heart patients who received injections of Trasylol-Aprotinin. Bayer responded by insisting that the study was inherently flawed, but it came to the attention of the Food and Drug Administration (FDA), who warned doctors and patients of the drug's adverse side effects, which include increased risk of heart attack, stroke, and even the deadly brain disease encephalopathy.
Though Bayer has tried to discredit this study and market the drug for other procedures (including hip replacement surgery), lawsuits have begun to flow in as more and more patients have been found who have experienced detrimental side effects from the use of Trasylol-Aprotinin in their heart surgeries.
Have You Suffered Side Effects?
If you or a loved one have suffered side effects, such as stroke, heart attack, encephalopathy or even death, after the use of Trasylol-Aprotinin in a surgical heart procedure, you may be eligible for compensation and damages for your lost wages, medical care, future medical care, loss of consort, and/or emotional and physical pain and suffering. Contact an experienced pharmaceutical attorney who can help you evaluate your claim and attain the compensation you deserve.
About the author
Use http://trasylol-aprotinin.legalview.com to garner more information on this ongoing investigation. Also use LegalView's other information portals to learn about controversial drugs similar to Trasylol Aprotinin such as the Avandia risks, found at http://avandia.legalview.com, or the Vytorin and Zetia side effects. from http://www.FreeArticlesAndContent.com
|
|
Copy This Article
For FREE!!!
You can use this article and copy it on your own website
for free! All you have to do is make sure the article
is copied with no changes and includes the "About
The Author" text. Also please ensure that all url's
are hyperlinked according. Thank you. |
Link To This Article - And We'll
Link Back To Your Website!
You are more then welcome to link to this article! All
you have to do is copy this webpage address from the
address bar and create a link on your website. Please
use the title of this article for your link text. Please
get in contact once you have linked to this article
and we'll link back to you! Thank you. |
|
|
|
Other great articles from this category...
|
Related Sites
|
|
